Comparing clinical outcomes of adults with obesity receiving tirzepatide versus bariatric metabolic surgery: A multi‐institutional propensity score‐matched study
Tirzepatide demonstrated superior clinical outcomes compared with BMS in adults with obesity, including significant reductions in all-cause mortality, MACEs and MAKEs. These findings suggest that tirzepatide may serve as an effective non-surgical alternative to BMS, with broad applicability across diverse patient populations.
Authors
- Tinghui Liu (ORCID: https://orcid.org/0009-0001-9634-3715)
- Po‐Yu Huang (ORCID: https://orcid.org/0000-0002-8682-1322)
- Chih‐Cheng Lai (ORCID: https://orcid.org/0000-0002-6334-2388)
- S.C Chan
- Tsung Yu (ORCID: https://orcid.org/0000-0002-5773-3665)
- Wan‐Hsuan Hsu (ORCID: https://orcid.org/0000-0002-2517-1792)
- Ya‐Wen Tsai (ORCID: https://orcid.org/0000-0003-4630-3923)
- Jheng‐Yan Wu (ORCID: https://orcid.org/0000-0002-3290-1909)
- Min‐Hsiang Chuang (ORCID: https://orcid.org/0000-0002-8538-4861)
- Chia‐Chih Kuo
Institutions
- National Sun Yat-sen University (TW)
- Chi Mei Medical Center (TW)
- National Cheng Kung University (TW)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-03-20
- DOI
- https://doi.org/10.1111/dom.16353
- Citations
- 11
- Primary Topic
- Bariatric Surgery and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 22.07